Market News / Story
Nvidia-backed Iambic seeks a valuation exceeding $800M in U.S. IPO
Seeking Alpha ·
Seeking Alpha reports: Iambic Therapeutics (IAM), a life sciences company backed by Nvidia and AbbVie , among others, on Thursday detailed its plans to go public at a valuation exceeding $800M through a Nasdaq listing. In a regulatory filing, Iambic (IAM), which leverages artificial intelligence to develop new medicines, announced its intention to sell roughly 9.4M shares of its common stock at $15.00 - $17.00 on the Nasdaq Global Select Market under the ticker symbol "IAM.” The San…